{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:39:58Z","timestamp":1793727598420,"version":"4.6.1"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00626, PI18\/00721, PI18-01695"],"award-info":[{"award-number":["PI18\/00626, PI18\/00721, PI18-01695"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>HLA-G is a non-classical HLA class I molecule with immunomodulatory properties. It was initially described at the maternal-fetal interface, and it was later found that this molecule was constitutively expressed on certain immuneprivileged tissues, such as cornea, endothelial and erythroid precursors, and thymus. The immunosuppressive effect of HLA-G is exerted through the interaction with its cognate receptors, expressed on immunocompetent cells, like ILT2, expressed on NK, B, T cells and APCs; ILT4, on APCs; KIR, found on the surface of NK cells; and finally, the co-receptor CD8. Because of these immunomodulatory functions, HLA-G has been involved in several processes, amongst which organ transplantation, viral infections, cancer progression, and autoimmunity. HLA-G neo-expression on tumors has been recently described in several types of malignancies. In fact, tumor progression is tightly linked to the presence of the molecule, as it exerts its tolerogenic function, inhibiting the cells of the immune system and favoring tumor escape. Several polymorphisms in the 3\u2019UTR region condition changes in HLA-G expression (14bp and +3142C\/G, among others), which have been associated with both the development and outcome of patients with different tumor types. Also, in recent years, several studies have shown that HLA-G plays an important role in the control of autoimmune diseases. The ability of HLA-G to limit the progression of these diseases has been confirmed and, in fact, levels of the molecule and several of its polymorphisms have been associated with increased susceptibility to the development of autoimmune diseases, as well as increased disease severity. Thus, modulating HLA-G expression in target tissues of oncology patients or patients with autoimmune diseases may be potential therapeutic approaches to treat these pathological conditions.<\/jats:p>","DOI":"10.3389\/fimmu.2022.796054","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:57:22Z","timestamp":1643284642000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Jos\u00e9 Manuel","family":"Mart\u00edn-Villa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Vaquero-Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Molina-Alejandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Su\u00e1rez-Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"L\u00f3pez-Nares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Palacio\u2010Gruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Barrera-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Fern\u00e1ndez-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rodr\u00edguez-Sainz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arnaiz-Villena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050295","article-title":"Immunotolerant Functions of HLA-G","volume":"55","author":"Carosella","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2326636","article-title":"A Class I Antigen, HLA-G, Expressed in Human Trophoblasts","volume":"48","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in Human Cornea, an Immune-Privileged Tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-0378(99)00036-4","article-title":"Primary Cultured Human Thymic Epithelial Cells Express Both Membrane-Bound and Soluble HLA-G Translated Products","volume":"43","author":"Mallet","year":"1999","journal-title":"J Reprod Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13099","article-title":"The Autoimmune Regulator (Aire) Transactivates HLA-G Gene Expression in Thymic Epithelial Cells","volume":"158","author":"Melo-Lima","year":"2019","journal-title":"Immunology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/BF02935526","article-title":"HLA non-A,B,C Class I Genes: Their Structure and Expression","volume":"9","author":"Heinrichs","year":"1990","journal-title":"Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00476","article-title":"Insights Into HLA-G Genetics Provided by Worldwide Haplotype Diversity","volume":"5","author":"Castelli","year":"2014","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0580-7","article-title":"Implications of the Polymorphism of HLA-G on its Function, Regulation, Evolution and Disease Association","volume":"68","author":"Donadi","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0198-8859(00)00197-x","article-title":"Identification of HLA-G7 as a New Splice Variant of the HLA-G mRNA and Expression of Soluble HLA-G5, -G6, and -G7 Transcripts in Human Transfected Cells","volume":"61","author":"Paul","year":"2000","journal-title":"Hum Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-001-0373-0","article-title":"HLA-G Unique Promoter Region: Functional Implications","volume":"53","author":"Solier","year":"2001","journal-title":"Immunogenetics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1006\/scbi.1998.0109","article-title":"The Regulation of HLA Class I Expression: Is HLA-G the Odd One Out","volume":"9","author":"Gobin","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24009-7","article-title":"The Genetic Diversity Within the 1.4 Kb HLA-G 5\u2032 Upstream Regulatory Region Moderately Impacts on Cellular Microenvironment Responses","volume":"8","author":"Dias","year":"2018","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/gene.2013.67","article-title":"Worldwide Genetic Variation at the 3\u2032 Untranslated Region of the HLA-G Gene: Balancing Selection Influencing Genetic Diversity","volume":"15","author":"Sabbagh","year":"2014","journal-title":"Genes Immun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00009","article-title":"The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases","volume":"6","author":"Dias","year":"2015","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","article-title":"HLA-G Allelic Variants are Associated With Differences in the HLA-G mRNA Isoform Profile and HLA-G mRNA Levels","volume":"55","author":"Hviid","year":"2003","journal-title":"Immunogenetics"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2008.01107.x","article-title":"The 14 Bp Deletion Polymorphisms in HLA-G Gene Play an Important Role in the Expression of Soluble HLA-G in Plasma","volume":"72","author":"Chen","year":"2008","journal-title":"Tissue Antigens"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2003.08.347","article-title":"The 14 Bp Deletion-Insertion Polymorphism in the 3\u2019 UT Region of the HLA-G Gene Influences HLA-G mRNA Stability","volume":"64","author":"Rousseau","year":"2003","journal-title":"Hum Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/521200","article-title":"Allele-Specific Targeting of microRNAs to HLA-G and Risk of Asthma","volume":"81","author":"Tan","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gan059","article-title":"A Single Base-Pair Mutation in the 3\u2019-Untranslated Region of HLA-G mRNA is Associated With Pre-Eclampsia","volume":"14","author":"Yie","year":"2008","journal-title":"Mol Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1431057100","article-title":"Human Inhibitory Receptors Ig-Like Transcript 2 (ILT2) and ILT4 Compete With CD8 for MHC Class I Binding and Bind Preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.4.1877","article-title":"Cutting Edge: Induction of IFN-Gamma Production But Not Cytotoxicity by the Killer Cell Ig-Like Receptor KIR2DL4 (CD158d) in Resting NK Cells","volume":"167","author":"Rajagopalan","year":"2001","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0378(99)00035-2","article-title":"Molecular Mechanisms Controlling Constitutive and IFN-\u03b3-Inducible HLA-G Expression in Various Cell Types","volume":"43","author":"Lefebvre","year":"1999","journal-title":"J Reprod Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.4.2514","article-title":"Ig-Like Transcript 2 (ILT2)\/leukocyte Ig-Like Receptor 1 (LIR1) Inhibits TCR Signaling and Actin Cytoskeleton Reorganization","volume":"166","author":"Dietrich","year":"2001","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s0165-0378(00)00070-x","article-title":"HLA-G Suppresses Proliferation of CD4(+) T-Lymphocytes","volume":"48","author":"Bainbridge","year":"2000","journal-title":"J Reprod Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.8.1351","article-title":"HLA-G-Mediated Inhibition of Antigen-Specific Cytotoxic T Lymphocytes","volume":"11","author":"Le Gal","year":"1999","journal-title":"Int Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1331","article-title":"Soluble HLA-G Inhibits Cell Cycle Progression in Human Alloreactive T Lymphocytes","volume":"176","author":"Bahri","year":"2006","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6100","article-title":"Cutting Edge: Soluble HLA-G1 Triggers CD95\/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting With CD8","volume":"164","author":"Fournel","year":"2000","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/immu.200390015","article-title":"-B,-C and -G Molecules Induce Apoptosis in T and NK CD8+ Cells and Inhibit Cytotoxic T Cell Activity Through CD8 Ligation","volume":"33","author":"Contini","year":"2003","journal-title":"Eur J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(01)02007-5","article-title":"HLA-G: A Shield Against Inflammatory Aggression","volume":"22","author":"Carosella","year":"2001","journal-title":"Trends Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.12.005","article-title":"NK Cytolysis is Dependent on the Proportion of HLA-G Expression","volume":"74","author":"Chen","year":"2013","journal-title":"Hum Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200002)30:2<586::AID-IMMU586>3.0.CO;2-Y","article-title":"HLA-G Inhibits the Transendothelial Migration of Human NK Cells","volume":"30","author":"Dorling","year":"2000","journal-title":"Eur J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.04-1617fje","article-title":"HLA-G Up-Regulates ILT2, ILT3, ILT4, and KIR2DL4 in Antigen Presenting Cells, NK Cells, and T Cells","volume":"19","author":"Lemaoult","year":"2005","journal-title":"FASEB J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.53","article-title":"HLA-G-Mediated NK Cell Senescence Promotes Vascular Remodeling: Implications for Reproduction","volume":"11","author":"Rajagopalan","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00394","article-title":"Interactions Between HLA-G and HLA-E in Physiological and Pathological Conditions","volume":"5","author":"Morandi","year":"2014","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a Major Ligand for the Natural Killer Inhibitory Receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300438","article-title":"Binding of HLA-G to ITIM-Bearing Ig-Like Transcript 2 Receptor Suppresses B Cell Responses","volume":"192","author":"Naji","year":"2014","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425741","article-title":"Tolerization of Dendritic Cells by HLA-G","volume":"35","author":"Ristich","year":"2005","journal-title":"Eur J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.113803","article-title":"HLA-G Expression Levels Influence the Tolerogenic Activity of Human DC-10","volume":"100","author":"Amodio","year":"2015","journal-title":"Haematologica"},{"key":"B39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12974-016-0584-9","article-title":"Cryopreserved Vitamin D3-Tolerogenic Dendritic Cells Pulsed With Autoantigens as a Potential Therapy for Multiple Sclerosis Patients","volume":"13","author":"Mansilla","year":"2016","journal-title":"J Neuroinflamm"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083139","article-title":"CD3+CD4low and CD3+CD8low are Induced by HLA-G: Novel Human Peripheral Blood Suppressor T-Cell Subsets Involved in Transplant Acceptance","volume":"110","author":"Naji","year":"2007","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.5.803","article-title":"IL-10 Selectively Induces HLA-G Expression in Human Trophoblasts and Monocytes","volume":"11","author":"Moreau","year":"1999","journal-title":"Int Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00639.x","article-title":"CTLA-4: A Key Regulatory Point in the Control of Autoimmune Disease","volume":"223","author":"Scalapino","year":"2008","journal-title":"Immunol Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000059","article-title":"Biochemical Signaling of PD-1 on T Cells and Its Functional Implications","volume":"20","author":"Boussiotis","year":"2014","journal-title":"Cancer J"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01613","article-title":"HLA-G Expressing Immune Cells in Immune Mediated Diseases","author":"Contini","year":"2020","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-015-0177-4","article-title":"TGF-\u03b2 Induces HLA-G Expression Through Inhibiting miR-152 in Gastric Cancer Cells","volume":"22","author":"Guan","year":"2015","journal-title":"J BioMed Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2008.32","article-title":"Intercellular Trogocytosis Plays an Important Role in Modulation of Immune Responses","volume":"5","author":"Ahmed","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1077","article-title":"Intercellular Transfer of HLA-G: Its Potential in Cancer Immunology","volume":"8","author":"Lin","year":"2019","journal-title":"Clin Trans Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune Regulation by Pretenders: Cell-to-Cell Transfers of HLA-G Make Effector T Cells Act as Regulatory Cells","volume":"109","author":"LeMaoult","year":"2006","journal-title":"Blood"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601570","article-title":"Trogocytosis-Based Generation of Suppressive NK Cells","volume":"26","author":"Caumartin","year":"2007","journal-title":"EMBO J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/297073","article-title":"HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy","volume":"2014","author":"Rebmann","year":"2014","journal-title":"J Immunol Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(00)02386-2","article-title":"Implication of HLA-G Molecule in Heart-Graft Acceptance","volume":"355","author":"Lila","year":"2000","journal-title":"Lancet"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1984.tb00721.x","article-title":"Mechanisms of Allograft Rejection: The Roles of Cytotoxic T-Cells and Delayed-Type Hypersensitivity","volume":"77","author":"Mason","year":"1984","journal-title":"Immunol Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(03)00354-4","article-title":"Human Leukocyte Antigen-G (HLA-G) Expression in Biliary Epithelial Cells Is Associated With Allograft Acceptance in Liver-Kidney Transplantation","volume":"39","author":"Cr\u00e9put","year":"2003","journal-title":"J Hepatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000015075.89984.46","article-title":"Human Leukocyte Antigen-G Expression After Heart Transplantation Is Associated With a Reduced Incidence of Rejection","volume":"105","author":"Lila","year":"2002","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2018.05.003","article-title":"10-Year Experience With HLA-G in Heart Transplantation","volume":"79","author":"Lazarte","year":"2018","journal-title":"Hum Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01417.x","article-title":"Soluble HLA-G Expression and Renal Graft Acceptance","volume":"6","author":"Qiu","year":"2006","journal-title":"Am J Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.24.15226-15237.2005","article-title":"Modulation of HLA-G Expression in Human Neural Cells After Neurotropic Viral Infections","volume":"79","author":"Lafon","year":"2005","journal-title":"J Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/298569","article-title":"Immunomodulatory Properties of HLA-G in Infectious Diseases","volume":"2014","author":"Amiot","year":"2014","journal-title":"J Immunol Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00592","article-title":"HLA-G Molecules in Autoimmune Diseases and Infections","volume":"5","author":"Rizzo","year":"2014","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1159\/000485819","article-title":"Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer","volume":"44","author":"Wan","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800751","article-title":"Human Leukocyte Antigen G Expression: As a Significant Prognostic Indicator for Patients With Colorectal Cancer","volume":"20","author":"Ye","year":"2007","journal-title":"Mod Pathol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0891-9","article-title":"HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro","volume":"17","author":"He","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2704","article-title":"Human Leukocyte Antigen\u2013G and Cancer Immunoediting","volume":"68","author":"Urosevic","year":"2008","journal-title":"Cancer Res"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28845","article-title":"In Vivo Evidence That Secretion of HLA-G by Immunogenic Tumor Cells Allows Their Evasion From Immunosurveillance","volume":"135","author":"Loumagne","year":"2014","journal-title":"Int J Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6784","article-title":"HLA-Mediated Tumor Escape Mechanisms That may Impair Immunotherapy Clinical Outcomes via T-Cell Activation","volume":"14","author":"Rodr\u00edguez","year":"2017","journal-title":"Oncol Lett"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/S12558-015-0361-6","article-title":"Function of HLA-G in Cancer Immunoediting and its Clinical Benefits","volume":"7","author":"Oucherif","year":"2015","journal-title":"Afr J Cancer"},{"key":"B67","article-title":"HLA-G is a Potential Tumor Marker in Malignant Ascites","volume":"9","author":"Singer","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2014.04.007","article-title":"Human Leukocyte Antigen G is Associated With Esophageal Squamous Cell Carcinoma Progression and Poor Prognosis","volume":"161","author":"Zheng","year":"2014","journal-title":"Immunol Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.698438","article-title":"HLA-G 3\u2019utr Polymorphisms Are Linked to Susceptibility and Survival in Spanish Gastric Adenocarcinoma Patients","author":"Vaquero-Yuste","year":"2021","journal-title":"Front Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-018-2379-0","article-title":"HLA-G Expression in Gastric Carcinoma: Clinicopathological Correlations and Prognostic Impact","volume":"473","author":"Murdaca","year":"2018","journal-title":"Virchows Arch"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144000","article-title":"HLA-G 3\u2019utr Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment","volume":"10","author":"Garziera","year":"2015","journal-title":"PloS One"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-019-02244-2","article-title":"HLA-G as a New Tumor Biomarker: Detection of Soluble Isoforms of HLA-G in the Serum and Saliva of Patients With Colorectal Cancer","volume":"22","author":"L\u00e1zaro-S\u00e1nchez","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-130364","article-title":"Association Between HLA-G 3\u2019UTR 14-Bp Ins\/Del Polymorphism and Susceptibility to Breast Cancer","volume":"13","author":"Eskandari-Nasab","year":"2013","journal-title":"Cancer Biomark"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-015-8782-6","article-title":"Association of HLA-G +3142 C>G Polymorphism and Breast Cancer in Tunisian Population","volume":"64","author":"Zidi","year":"2016","journal-title":"Immunol Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/1354750X.2011.633242","article-title":"Relationship Between HLA-G Gene Polymorphism and the Susceptibility of Esophageal Cancer in Kazakh and Han Nationality in Xinjiang","volume":"17","author":"Chen","year":"2012","journal-title":"Biomarkers"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2007.06.011","article-title":"Expression of Human Leucocyte Antigen G (HLA-G) is Associated With Prognosis in non-Small Cell Lung Cancer","volume":"58","author":"Yie","year":"2007","journal-title":"Lung Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2011.1238","article-title":"Association of HLA-G 3\u2032 UTR 14-Bp Insertion\/Deletion Polymorphism With Hepatocellular Carcinoma Susceptibility in a Chinese Population","volume":"30","author":"Jiang","year":"2011","journal-title":"DNA Cell Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0463","article-title":"Human Leukocyte Antigen-G Protein Expression is an Unfavorable Prognostic Predictor of Hepatocellular Carcinoma Following Curative Resection","volume":"15","author":"Cai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2009.01302.x","article-title":"Characterization of HLA-G Expression in Renal Cell Carcinoma","volume":"74","author":"Li","year":"2009","journal-title":"Tissue Antigens"},{"key":"B80","first-page":"28","article-title":"Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions","volume":"15","author":"Khodabandeh Shahraki","year":"2018","journal-title":"Iran J Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158265","article-title":"A Critical Assessment of the Association Between HLA-G Expression by Carcinomas and Clinical Outcome","volume":"22","author":"van de Water","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02164","article-title":"Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges","author":"Lin","year":"2018","journal-title":"Front Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.565759","article-title":"Intratumor Heterogeneity of HLA-G Expression in Cancer Lesions","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2003.10.005","article-title":"The 4H84 Monoclonal Antibody Detecting Beta2m Free Nonclassical HLA-G Molecules Also Binds to Free Heavy Chains of Classical HLA Class I Antigens Present on Activated Lymphocytes","volume":"65","author":"Pol\u00e1kov\u00e1","year":"2004","journal-title":"Hum Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3731","article-title":"The Multiple Pathways to Autoimmunity","volume":"18","author":"Theofilopoulos","year":"2017","journal-title":"Nat Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4326495","article-title":"Recent Advances in Our Understanding of HLA-G Biology: Lessons From a Wide Spectrum of Human Diseases","volume":"2016","author":"Morandi","year":"2016","journal-title":"J Immunol Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308098187","article-title":"Association of the HLA-G 14 Bp Polymorphism With Systemic Lupus Erythematosus","volume":"18","author":"Veit","year":"2009","journal-title":"Lupus"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2011.01635.x","article-title":"Association of the HLA-G Gene +3142C>G Polymorphism With Systemic Lupus Erythematosus","volume":"77","author":"Consiglio","year":"2011","journal-title":"Tissue Antigens"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2008.01037.x","article-title":"HLA-G Genotype and HLA-G Expression in Systemic Lupus Erythematosus: HLA-G as a Putative Susceptibility Gene in Systemic Lupus Erythematosus","volume":"71","author":"Rizzo","year":"2008","journal-title":"Tissue Antigens"},{"key":"B90","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple Sclerosis - A Review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.11.019","article-title":"An Investigation Into the Association Between HLA-G 14 Bp Insertion\/Deletion Polymorphism and Multiple Sclerosis Susceptibility","volume":"290","author":"Mohammadi","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.imlet.2016.10.006","article-title":"The Association Between Functional HLA-G 14bp Insertion\/Deletion and +3142 C>G Polymorphisms and Susceptibility to Multiple Sclerosis","volume":"180","author":"Ben Fredj","year":"2016","journal-title":"Immunol Lett"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"B94","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/08820139.2019.1657146","article-title":"Association of HLA-G 3\u2019utr Polymorphisms With Soluble HLA-G Levels and Disease Activity in Patients With Rheumatoid Arthritis: A Case-Control Study","volume":"49","author":"Gautam","year":"2020","journal-title":"Immunol Invest"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3155-3","article-title":"Meta-Analysis of Associations Between Functional HLA-G Polymorphisms and Susceptibility to Systemic Lupus Erythematosus and Rheumatoid Arthritis","volume":"35","author":"Lee","year":"2015","journal-title":"Rheumatol Int"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.36295\/ASRO.2019.220918","article-title":"Genetic Role of HLA-G 14 Base Pair INDEL Polymorphic Gene With Type 1 Diabetic Patients","volume":"22","author":"Shareef","year":"2019","journal-title":"Ann Trop Med Public Health"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2016.02.001","article-title":"Association of HLA-G 3\u2019 Untranslated Region Variants With Type 1 Diabetes Mellitus","volume":"77","author":"de Albuquerque","year":"2016","journal-title":"Hum Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12140","article-title":"HLA-G 14-Bp Polymorphism: A Possible Marker of Systemic Treatment Response in Psoriasis Vulgaris? Preliminary Results Retrospective Study","volume":"27","author":"Borghi","year":"2014","journal-title":"Dermatol Ther"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56462-3","article-title":"AAV-Mediated Expression of HLA-G1\/5 Reduces Severity of Experimental Autoimmune Uveitis","volume":"9","author":"Crabtree","year":"2019","journal-title":"Sci Rep"},{"key":"B100","first-page":"126","article-title":"Increased Risk of Human Leukocyte Antigen-G Gene Variants in Beh\u00e7et\u2019s Disease","volume":"24","author":"Park","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2006.00742.x","article-title":"HLA-E*0101 and HLA-G*010101 Reduce the Risk of Behcet\u2019s Disease","volume":"69","author":"Park","year":"2007","journal-title":"Tissue Antigens"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2017.03.030","article-title":"Down-Regulation of HLA-G Gene Expression as an Immunogenetic Contraceptive Therapy","volume":"102","author":"Kaminski","year":"2017","journal-title":"Med Hypotheses"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520970758","article-title":"The microRNA-152\/Human Leukocyte Antigen-G Axis Affects Proliferation and Immune Escape of non-Small Cell Lung Cancer Cells","volume":"48","author":"Fu","year":"2020","journal-title":"J Int Med Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12708","article-title":"Combination Therapy Strategies for Improving PD-1 Blockade Efficacy: A New Era in Cancer Immunotherapy","volume":"283","author":"Chowdhury","year":"2018","journal-title":"J Internal Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0764","article-title":"CD8+PD-1-ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-G","volume":"7","author":"Dumont","year":"2019","journal-title":"Cancer Immunol Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.796054\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:57:29Z","timestamp":1643284649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.796054\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":105,"alternative-id":["10.3389\/fimmu.2022.796054"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.796054","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"article-number":"796054"}}